英文摘要 |
The over-the-counter (OTC) derivative has been accredited as a primary factor that caused the financial avalanche of 2008-2009. In the aftermath of massive bank bailouts and housing crises, government regulators, investors and banking institutions were forced to acknowledge that the derivatives market could not continue on unregulated, as it continued to pose significant risks to the global financial system. However, how to gain regulatory control over futures contracts was a dilemma faced by all, and which prompted pioneering actions by a few global agencies, and eventually the by the United States. Reformatory committees and regulators have since focused upon the potential risks of an unregulated OTC derivative market, mainly the counterparty risk, trade recording, central clearings, and higher capital and minimum margins for uncleared swaps. Challenges of global inconsistencies between regulators, arbitrage, transaction costs and market fragmentation plagued efforts of regulatory regimes, including the Dodd-Frank Wall Street Reform Act and the Basel International Framework for Banks. A qualitative review of literature is conducted to contrast and compare perspectives of national OTC regulatory frameworks, the impact of the Dodd-Frank Act on the global OTC derivatives markets, and proposed solutions to the existing inconsistencies between national regulatory implementations. This study will review and analyze the outcomes of the review in order to better define and draw a conclusion in regard to the ramifications of an effective co-regulation framework for the OTC derivatives market regulatory regimes that proves to be globally harmonic. The solution, as found by the research, is to institute properly formulated counter-measures of OTC transacttions through a framework of vested institutional policy-makers. |